We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
201
Gossamer Bio
GOSS
$75.6M
$1.64M 0.01%
+202,326
New +$1.75M
LDHA
202
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$1.46M 0.01%
+150,000
New +$1.47M
AEON icon
203
AEON Biopharma
AEON
$9.58M
$1.45M 0.01%
+2,083
New +$1.46M
TBPH icon
204
Theravance Biopharma
TBPH
$883M
$1.39M 0.01%
+96,000
New +$1.8M
BRMK.WS
205
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$1.29M 0.01%
7,174,613
– –
PHVS icon
206
Pharvaris
PHVS
$2.55B
$1.29M 0.01%
71,020
-128,980
-64% -$2.93M
TMAC
207
DELISTED
The Music Acquisition Corporation
TMAC
$1.21M ﹤0.01%
+125,000
New +$1.22M
EDU icon
208
New Oriental
EDU
$8.88B
$1.06M ﹤0.01%
13,000
-1,581,300
-99% -$192M
NSTD
209
DELISTED
Northern Star Investment Corp. IV
NSTD
$985K ﹤0.01%
+100,000
New +$981K
NSTC
210
DELISTED
Northern Star Investment Corp. III
NSTC
$978K ﹤0.01%
+100,000
New +$981K
RUM icon
211
RUM Group Inc
RUM
$4.49B
$974K ﹤0.01%
+100,000
New +$977K
GOL
212
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$791K ﹤0.01%
85,838
– –
ASPC
213
DELISTED
Alpha Capital Acquisition Co
ASPC
$773K ﹤0.01%
+79,598
New +$772K
SLAM
214
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$687K ﹤0.01%
+70,508
New +$688K
TINV.WS
215
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$605K ﹤0.01%
540,000
– –
SPAQ
216
DELISTED
Spartan Acquisition Corp. III
SPAQ
$587K ﹤0.01%
+60,053
New +$591K
REVHW
217
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$560K ﹤0.01%
+400,000
New +$509K
CAS.WS
218
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$470K ﹤0.01%
495,000
– –
ASZ.WS
219
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$469K ﹤0.01%
+375,000
New +$410K
BSKYW
220
DELISTED
Big Sky Growth Partners, Inc. Warrant
BSKYW
$461K ﹤0.01%
+387,500
New +$419K
KAHC.WS
221
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$443K ﹤0.01%
+375,000
New +$433K
DISAW
222
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$429K ﹤0.01%
+466,667
New +$447K
AGGRW
223
DELISTED
Agile Growth Corp Warrant
AGGRW
$380K ﹤0.01%
+399,999
New +$316K
FRXB.WS
224
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$349K ﹤0.01%
+250,000
New +$269K
CRZNW
225
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$340K ﹤0.01%
+333,334
New +$291K
7 8
9
10 11

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.